Current Management of Basal Cell Carcinoma

Manuel Krieter; Erwin Schultz

doi:10.1055/a-1861-7077

Current Management of Basal Cell Carcinoma

Manuel Krieter^* (First author), Erwin Schultz (Last author)

^*Corresponding author for this work

Department of Dermatology

Research output: Contribution to journal › Original Article › peer-review

Original language	German
Pages (from-to)	969-978
Journal	LARYNGO-RHINO-OTOLOGIE
Volume	101
Issue number	12
DOIs	https://doi.org/10.1055/a-1861-7077
Publication status	Published - 2022

Keywords

SKIN-CANCER
PHOTODYNAMIC THERAPY
DOUBLE-BLIND
VISMODEGIB
CONSENSUS
RISK
DIAGNOSIS
IMIQUIMOD
TRIAL

Access to Document

10.1055/a-1861-7077

Cite this

@article{0eca4895053c4aca87519949bec6dc68,

title = "Current Management of Basal Cell Carcinoma",

keywords = "SKIN-CANCER, PHOTODYNAMIC THERAPY, DOUBLE-BLIND, VISMODEGIB, CONSENSUS, RISK, DIAGNOSIS, IMIQUIMOD, TRIAL",

author = "Manuel Krieter and Erwin Schultz",

note = "Krieter, Schultz: Universit{\"a}tsklinik f{\"u}r Dermatologie, Paracelsus Medizinische Privatuniversit{\"a}t N{\"u}rnberg, N{\"u}rnberg, Deutschland",

year = "2022",

doi = "10.1055/a-1861-7077",

language = "Deutsch",

volume = "101",

pages = "969--978",

journal = "LARYNGO-RHINO-OTOLOGIE",

issn = "0935-8943",

number = "12",

}

TY - JOUR

T1 - Current Management of Basal Cell Carcinoma

AU - Krieter, Manuel

AU - Schultz, Erwin

N1 - Krieter, Schultz: Universitätsklinik für Dermatologie, Paracelsus Medizinische Privatuniversität Nürnberg, Nürnberg, Deutschland

PY - 2022

Y1 - 2022

KW - SKIN-CANCER

KW - PHOTODYNAMIC THERAPY

KW - DOUBLE-BLIND

KW - VISMODEGIB

KW - CONSENSUS

KW - RISK

KW - DIAGNOSIS

KW - IMIQUIMOD

KW - TRIAL

U2 - 10.1055/a-1861-7077

DO - 10.1055/a-1861-7077

M3 - Originalarbeit

C2 - 36513089

SN - 0935-8943

VL - 101

SP - 969

EP - 978

JO - LARYNGO-RHINO-OTOLOGIE

JF - LARYNGO-RHINO-OTOLOGIE

IS - 12

ER -